Population pharmacokinetics and exposure–response relationships of dostarlimab in primary advanced or recurrent endometrial cancer in part 1 of RUBY
- Mita Kuchimanchi
- , Trine Lembrecht Jørgensen
- , Eva Hanze
- , Thierry André
- , Angela Jain
- , Dominique Berton
- , Oskar Alskär
- , Oleksandr Zub
- , Ana Oaknin
- , Mark S. Shahin
- , Anthoula Koliadi
- , Bhavana Pothuri
- , Tom Krivak
- , Mikalai Pishchyk
- , Yakir Segev
- , Floor J. Backes
- , Christine Gennigens
- , Sara Bouberhan
- , Stefan Zajic
- , Murad Melhem
Research output: Contribution to journal › Article › peer-review
2
Link opens in a new tab
Scopus
citations